leadf
logo-loader
viewEpsilon Healthcare Ltd
(
ASX:EPN
)

THC Global granted manufacturing licence by Australian Office of Drug Control

THC Global Group Ltd (ASX:THC) chief executive officer Ken Charteris updates Proactive Investors on the manufacturing licence granted to the cannabis company by the Australian Office of Drug Control.
 
"It's a significnat milestone ... we now are a farm-to-pharma process which means that we grow, and we actually then process to a complete medicine," says Charteris. 
 
He continues, "This is a great position for us to be in and we're the only company presently that holds the whole suite and also have their own breeds and processing. 
 
"The bigger news for us is that we're a global company - this now allows us to produce and formulate our own brands with our own products."

Quick facts: Epsilon Healthcare Ltd

Follow
ASX:EPN

Price: 0.125 AUD

Market Cap: $24.09 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Base Resources highlights enhanced DFS for Toliara project in Madagascar

Base Resources Ltd's Kevin Balloch talks Proactive through an enhanced definitive feasibility study on its Toliara project in Madagascar. It's revealed a post-tax/pre-debt net present value of US$1bn and a 3.5 average revenue to cost of sales ratio over an initial 38-year mine life. Life-of-mine...

1 hour, 38 minutes ago

2 min read